Klebsiella pneumoniae co-producing KPC and RmtG, finally targeting Switzerland
Mancini, StefanoEmerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Switzerland - French INSERM European Unit, University of Fribourg (LEA-IAME), Fribourg, Switzerland - Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland.
Poirel, LaurentEmerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Switzerland - French INSERM European Unit, University of Fribourg (LEA-IAME), Fribourg, Switzerland - Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland.
Corthesy, MyriamInstitute for Microbiology, University of Lausanne and University Hospital Center, Lausanne, Switzerland
Greub, GilbertInstitute for Microbiology, University of Lausanne and University Hospital Center, Lausanne, Switzerland
Nordmann, PatriceEmerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Switzerland - French INSERM European Unit, University of Fribourg (LEA-IAME), Fribourg, Switzerland - Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland.
06.11.2017
Published in:
Diagnostic Microbiology and Infectious Disease. - 2018, vol. 90, no. 2, p. 151-152
English
A carbapenem- and pan-aminoglycoside-resistant Klebsiella pneumoniae strain was isolated from a Brazilian patient hospitalized in a Swiss hospital.The clinical isolate carried genes encoding the KPC-2 carbapenemase and the RmtG 16S rRNA methyltransferase.This is the first report of a carbapenem-resistant K. pneumoniae producing RmtG in Europe